NO821268L - Fremgangsmaate for forbedring av melkedannelse hos droevtyggere - Google Patents
Fremgangsmaate for forbedring av melkedannelse hos droevtyggereInfo
- Publication number
- NO821268L NO821268L NO821268A NO821268A NO821268L NO 821268 L NO821268 L NO 821268L NO 821268 A NO821268 A NO 821268A NO 821268 A NO821268 A NO 821268A NO 821268 L NO821268 L NO 821268L
- Authority
- NO
- Norway
- Prior art keywords
- milk
- antibiotic
- virginiamycin
- production
- group
- Prior art date
Links
- 239000008267 milk Substances 0.000 title claims abstract description 67
- 235000013336 milk Nutrition 0.000 title claims abstract description 66
- 210000004080 milk Anatomy 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title claims description 30
- 230000006872 improvement Effects 0.000 title description 10
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 claims abstract description 41
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 claims abstract description 39
- 241000282849 Ruminantia Species 0.000 claims abstract description 38
- 239000004188 Virginiamycin Substances 0.000 claims abstract description 33
- 235000019373 virginiamycin Nutrition 0.000 claims abstract description 33
- 230000003115 biocidal effect Effects 0.000 claims abstract description 31
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 27
- 108010080702 Virginiamycin Proteins 0.000 claims abstract description 25
- 229960003842 virginiamycin Drugs 0.000 claims abstract description 25
- 210000004767 rumen Anatomy 0.000 claims description 18
- NTAHMPNXQOYXSX-WKSONYIQSA-N goldinodox Chemical compound C(/[C@H]1O[C@H]([C@H]([C@H]1O)O)[C@H](C)[C@H](OC)C(/C)=C/C=C/CNC(=O)[C@@H](CC)[C@]1(O)[C@@H]([C@H](O)C(C)(C)[C@H](\C=C\C=C/C)O1)O)=C\C=C\C=C(/C)C(=O)C1=C(O)C=CN(C)C1=O NTAHMPNXQOYXSX-WKSONYIQSA-N 0.000 claims description 8
- -1 vernomycin Chemical compound 0.000 claims description 8
- SATIISJKSAELDC-UHFFFAOYSA-N etamycin Chemical compound CC1OC(=O)C(C=2C=CC=CC=2)N(C)C(=O)C(C)NC(=O)C(C(C)C(C)C)N(C)C(=O)CN(C)C(=O)C2CC(O)CN2C(=O)C(CC(C)C)NC(=O)C1NC(=O)C1=NC=CC=C1O SATIISJKSAELDC-UHFFFAOYSA-N 0.000 claims description 6
- RLNUPSVMIYRZSM-UHFFFAOYSA-N patricin Chemical compound CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC(=CC=2)N(C)C)CCN(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O RLNUPSVMIYRZSM-UHFFFAOYSA-N 0.000 claims description 5
- VKGDSUWMXCVJEA-ZODLGNRVSA-N (2S)-2-[(2S,4S,6S)-2,4-dihydroxy-5,5-dimethyl-6-[(1E,3E)-penta-1,3-dienyl]oxan-2-yl]-N-[(2E,4E,6S,7R)-7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-[(1E,3E,5E)-7-(4-hydroxy-1-methyl-2-oxopyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]butanamide Chemical compound C(/[C@H]1O[C@H]([C@H]([C@H]1O)O)[C@H](C)[C@H](OC)C(/C)=C/C=C/CNC(=O)[C@@H](CC)[C@@]1(O)O[C@H](C(C)(C)[C@@H](O)C1)\C=C\C=C\C)=C\C=C\C=C(/C)C(=O)C1=C(O)C=CN(C)C1=O VKGDSUWMXCVJEA-ZODLGNRVSA-N 0.000 claims description 4
- DAIKHDNSXMZDCU-OUDXUNEISA-N pristinamycin-IIA Natural products CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)C=C(C)C=CCNC(=O)C=C[C@@H]1C)n3 DAIKHDNSXMZDCU-OUDXUNEISA-N 0.000 claims description 4
- JOOMGSFOCRDAHL-XKCHLWDXSA-N pristinamycin-IIB Natural products CC(C)[C@@H]1OC(=O)[C@H]2CCCN2C(=O)c3coc(CC(=O)C[C@@H](O)C=C(C)C=CCNC(=O)C=C[C@H]1C)n3 JOOMGSFOCRDAHL-XKCHLWDXSA-N 0.000 claims description 4
- SATIISJKSAELDC-ZIOPZPSVSA-N 3-hydroxy-N-[(3R,6S,7R,10S,13S,16S,22R,24R)-24-hydroxy-7,11,13,17,20-pentamethyl-16-[(2S)-3-methylbutan-2-yl]-3-(2-methylpropyl)-2,5,9,12,15,18,21-heptaoxo-10-phenyl-8-oxa-1,4,11,14,17,20-hexazabicyclo[20.3.0]pentacosan-6-yl]pyridine-2-carboxamide Chemical compound CC(C)C[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](N(C)C(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]2C[C@@H](O)CN2C1=O)c1ccccc1 SATIISJKSAELDC-ZIOPZPSVSA-N 0.000 claims description 3
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 claims description 3
- HMSYAPGFKGSXAJ-PAHGNTJYSA-N Mocimycin Chemical compound C(/[C@H]1O[C@H]([C@H]([C@H]1O)O)[C@H](C)[C@H](OC)C(/C)=C/C=C/CNC(=O)[C@@H](CC)[C@]1(O)[C@@H]([C@H](O)C(C)(C)[C@H](\C=C\C=C/C)O1)O)=C\C=C\C=C(/C)C(=O)C1=C(O)NC=CC1=O HMSYAPGFKGSXAJ-PAHGNTJYSA-N 0.000 claims description 3
- 229930192776 Ostreogrycin Natural products 0.000 claims description 3
- 108010079780 Pristinamycin Proteins 0.000 claims description 3
- 108010034396 Streptogramins Proteins 0.000 claims description 3
- NTAHMPNXQOYXSX-UHFFFAOYSA-N goldinomycin Natural products CCC(C(=O)NCC=CC=C(C)C(OC)C(C)C1OC(C=CC=CC=C(C)C(=O)c2c(O)ccn(C)c2=O)C(O)C1O)C1(O)OC(C=CC=CC)C(C)(C)C(O)C1O NTAHMPNXQOYXSX-UHFFFAOYSA-N 0.000 claims description 3
- UXWOXTQWVMFRSE-SXTNSRNPSA-N griseoviridin Chemical compound C([C@H](OC1=O)C)\C=C(C(NC/C=C\C=C/[C@@H](O)C[C@@H](O)C2)=O)/SC[C@H]1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-SXTNSRNPSA-N 0.000 claims description 3
- 108010033580 griseoviridin Proteins 0.000 claims description 3
- XMKLKZFSQXZUQU-UHFFFAOYSA-N neoviridogrisein-II Natural products CC1OC(=O)C(C=2C=CC=CC=2)N(C)C(=O)C(C)NC(=O)C(C(C)C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(CC(C)C)NC(=O)C1NC(=O)C1=NC=CC=C1O XMKLKZFSQXZUQU-UHFFFAOYSA-N 0.000 claims description 3
- 229960003961 pristinamycin Drugs 0.000 claims description 3
- PCRZFPGJPKPMQB-LNQSXZRDSA-N 2-[(3r,6s,7s,10s,13s,16s,19s)-16-[[4-(dimethylamino)phenyl]methyl]-3-ethyl-6-[(3-hydroxypyridine-2-carbonyl)amino]-7,17-dimethyl-2,5,9,12,15,18-hexaoxo-10-phenyl-8-oxa-1,4,11,14,17-pentazabicyclo[17.3.0]docosan-13-yl]acetic acid Chemical compound N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)O[C@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O PCRZFPGJPKPMQB-LNQSXZRDSA-N 0.000 claims description 2
- PCRZFPGJPKPMQB-UHFFFAOYSA-N Doricin Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C(CC(O)=O)NC(=O)C(CC=2C=CC(=CC=2)N(C)C)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O PCRZFPGJPKPMQB-UHFFFAOYSA-N 0.000 claims description 2
- 108010046774 Mikamycin Proteins 0.000 claims description 2
- 229930192051 Mikamycin Natural products 0.000 claims description 2
- WYCWGSNHDCKSJO-UHFFFAOYSA-N aurodox Natural products CCC(C(=O)NCC=CC=C(/C)C(OC)C(C)C1OC(C=CC=CC=C(/C)C(=O)C2=C(O)CCN(C)C2=O)C(O)C1O)C3(O)OC(C=CC=C/C)C(C)(C)C(O)C3O WYCWGSNHDCKSJO-UHFFFAOYSA-N 0.000 claims description 2
- 229950003445 efrotomycin Drugs 0.000 claims description 2
- 229950007764 mikamycin Drugs 0.000 claims description 2
- 229950008095 mocimycin Drugs 0.000 claims description 2
- HMSYAPGFKGSXAJ-KNHRXMRASA-N mocimycin Natural products C([C@H]1O[C@H]([C@H]([C@H]1O)O)[C@H](C)[C@H](OC)C(C)=CC=CCNC(=O)[C@@H](CC)[C@]1(O)[C@@H]([C@H](O)C(C)(C)[C@H](C=CC=CC)O1)O)=CC=CC=C(C)C(=O)C1=C(O)NC=CC1=O HMSYAPGFKGSXAJ-KNHRXMRASA-N 0.000 claims description 2
- 108010015791 Streptogramin A Proteins 0.000 claims 1
- ASOJLQIBBYOFDE-HCHBIZCOSA-N chembl2106443 Chemical compound C(/[C@H]1O[C@H]([C@H]([C@H]1O)O)[C@H](C)[C@H](OC)C(/C)=C/C=C/CNC(=O)[C@@H](CC)[C@]1(O)[C@@H]([C@H](O[C@H]2[C@@H]([C@H](OC)[C@H](O[C@H]3[C@@H]([C@H](O)[C@@H](OC)[C@H](C)O3)OC)[C@@H](C)O2)O)C(C)(C)[C@H](\C=C\C=C\C)O1)O)=C\C=C\C=C(/C)C(=O)C1=C(O)C=CN(C)C1=O ASOJLQIBBYOFDE-HCHBIZCOSA-N 0.000 claims 1
- DAIKHDNSXMZDCU-FQTGFAPKSA-N pristinamycin IIA Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2 DAIKHDNSXMZDCU-FQTGFAPKSA-N 0.000 claims 1
- DAIKHDNSXMZDCU-UHFFFAOYSA-N pristinamycin component IIA Natural products C1C(=O)CC(O)C=C(C)C=CCNC(=O)C=CC(C)C(C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2 DAIKHDNSXMZDCU-UHFFFAOYSA-N 0.000 claims 1
- 108700007112 virginiamycin M2 Proteins 0.000 claims 1
- JOOMGSFOCRDAHL-WPZKFCHQSA-N volpristin Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)[C@H]2CCCN2C(=O)C2=COC1=N2 JOOMGSFOCRDAHL-WPZKFCHQSA-N 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 abstract description 19
- 241001465754 Metazoa Species 0.000 description 24
- 150000001875 compounds Chemical class 0.000 description 19
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 12
- 241000283690 Bos taurus Species 0.000 description 11
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000012530 fluid Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 235000013365 dairy product Nutrition 0.000 description 6
- 235000021243 milk fat Nutrition 0.000 description 6
- 240000008042 Zea mays Species 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 244000144972 livestock Species 0.000 description 4
- 241001494479 Pecora Species 0.000 description 3
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000009973 maize Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- ASOJLQIBBYOFDE-SBHXXGSWSA-N (2S)-2-[(2R,3R,4R,6S)-2,3-dihydroxy-4-[(2S,3R,4S,5R,6R)-3-hydroxy-5-[(2S,3R,4R,5R,6S)-4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,5-dimethyl-6-[(1E,3Z)-penta-1,3-dienyl]oxan-2-yl]-N-[(2E,4E,6S,7R)-7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-[(1E,3E,5E)-7-(4-hydroxy-1-methyl-2-oxopyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]butanamide Chemical compound O([C@H]1[C@@H](OC)[C@H]([C@@H](O[C@@H]1C)O[C@H]1[C@H]([C@@](O[C@@H](\C=C\C=C/C)C1(C)C)(O)[C@H](CC)C(O)=NC\C=C\C=C(/C)[C@@H](OC)[C@@H](C)[C@@H]1O[C@@H]([C@@H]([C@@H]1O)O)\C=C\C=C\C=C(/C)C(=O)c1c(n(C)ccc1O)=O)O)O)[C@H]1[C@H](OC)[C@H](O)[C@@H](OC)[C@H](C)O1 ASOJLQIBBYOFDE-SBHXXGSWSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 2
- 229930191564 Monensin Natural products 0.000 description 2
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- 235000019625 fat content Nutrition 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000003520 lipogenic effect Effects 0.000 description 2
- 239000004462 maize silage Substances 0.000 description 2
- 229960005358 monensin Drugs 0.000 description 2
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 2
- 239000011236 particulate material Substances 0.000 description 2
- 229950004240 plauracin Drugs 0.000 description 2
- 108010017575 plauracin Proteins 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241000187844 Actinoplanes Species 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- VKGDSUWMXCVJEA-UHFFFAOYSA-N Heneicomycin Natural products CCC(C(=O)NCC=CC=C(/C)C(OC)C(C)C1OC(C=CC=CC=C(/C)C(=O)C2=C(O)C=CN(C)C2=O)C(O)C1O)C3(O)CC(O)C(C)(C)C(O3)C=CC=C/C VKGDSUWMXCVJEA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930190515 Madumycin Natural products 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000283903 Ovis aries Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910021446 cobalt carbonate Inorganic materials 0.000 description 1
- ZOTKGJBKKKVBJZ-UHFFFAOYSA-L cobalt(2+);carbonate Chemical compound [Co+2].[O-]C([O-])=O ZOTKGJBKKKVBJZ-UHFFFAOYSA-L 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002394 glycogenic effect Effects 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002460 polyether antibiotic agent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Networks Using Active Elements (AREA)
- Control Of El Displays (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
- Medicinal Preparation (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/255,901 US4336250A (en) | 1981-04-20 | 1981-04-20 | Lactation improvement method |
Publications (1)
Publication Number | Publication Date |
---|---|
NO821268L true NO821268L (no) | 1982-10-21 |
Family
ID=22970327
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO821268A NO821268L (no) | 1981-04-20 | 1982-04-19 | Fremgangsmaate for forbedring av melkedannelse hos droevtyggere |
Country Status (17)
Country | Link |
---|---|
US (1) | US4336250A (fr) |
EP (1) | EP0063490B1 (fr) |
JP (1) | JPS57181016A (fr) |
AT (1) | ATE16886T1 (fr) |
AU (1) | AU548281B2 (fr) |
DE (1) | DE3267876D1 (fr) |
DK (1) | DK173682A (fr) |
FI (1) | FI821347L (fr) |
GB (1) | GB2098479B (fr) |
GR (1) | GR76132B (fr) |
HU (1) | HU183897B (fr) |
IE (1) | IE53057B1 (fr) |
IL (1) | IL65523A (fr) |
NO (1) | NO821268L (fr) |
NZ (1) | NZ200343A (fr) |
PH (1) | PH16912A (fr) |
ZA (1) | ZA822658B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4534969A (en) * | 1983-09-19 | 1985-08-13 | The Dow Chemical Company | Method for improving lactation in ruminant animals |
US4800213A (en) * | 1987-08-03 | 1989-01-24 | Eastman Kodak Company | Novel diethanolamine triacetic acid triamides and methods for improving feed utilization and lactation in ruminant animals |
US4895951A (en) * | 1987-08-03 | 1990-01-23 | Eastman Kodak Company | Heterocyclic diamides and method for improving feed utilization and lactation in ruminant animals |
US4801618A (en) * | 1987-08-03 | 1989-01-31 | Eastman Kodak Company | Methods for improving feed utilization and lactation in ruminant animals |
US5041452A (en) * | 1987-08-03 | 1991-08-20 | Eastman Kodak Company | Novel diamides and method for improving feed utilization and lactation in ruminant animals |
US4883820A (en) * | 1987-08-03 | 1989-11-28 | Eastman Kodak Company | Methods for improving feed utilization and lactation in ruminant animals |
US4966917A (en) * | 1987-08-03 | 1990-10-30 | Eastman Kodak Company | Methods for improving feed utilization and lactation in ruminant animals |
US4882355A (en) * | 1987-08-03 | 1989-11-21 | Eastman Kodak Company | Novel diethanolamine triactic acid triamides and methods for improving feed utilization and lactation in ruminant animals |
US4978682A (en) * | 1987-08-03 | 1990-12-18 | Eastman Kodak Company | Novel diethanolamine triacetic acid triamides and methods for improving feed utilization and lactation in ruminant animals |
CA1336811C (fr) * | 1988-03-30 | 1995-08-29 | James Baber Rowe | Traitement de betail chevalin a l'aide d'antibiotiques |
FR2657873B1 (fr) * | 1990-02-08 | 1992-04-17 | Rhone Poulenc Sante | Nouvelle elfamycine, son procede de preparation et son utilisation. |
US8519008B2 (en) | 2003-01-22 | 2013-08-27 | Purina Animal Nutrition Llc | Method and composition for improving the health of young monogastric mammals |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3923981A (en) * | 1970-08-14 | 1975-12-02 | Gist Brocades Nv | Antibiotic MYC 8003 |
US3839557A (en) * | 1972-01-24 | 1974-10-01 | Lilly Co Eli | Antibiotics monensin and a204 for improving ruminant feed efficiency |
US3923980A (en) * | 1972-07-31 | 1975-12-02 | Lilly Co Eli | Antibiotic A-2315 and process for preparation thereof |
US3898327A (en) * | 1974-04-22 | 1975-08-05 | Squibb & Sons Inc | Antibiotic azdimycin |
JPS52151191A (en) * | 1976-06-10 | 1977-12-15 | Sanraku Inc | Novel antibiotics neoviridogriseins and their preparation |
US4218437A (en) * | 1976-07-23 | 1980-08-19 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Animal feeds containing a mixture of virginiamycin, zinc bacitracin or flavophospholipol and proteolytic enzymes |
DE2753309A1 (de) * | 1977-11-30 | 1979-05-31 | Henkel Kgaa | Tierfuttermischung |
US4071631A (en) * | 1976-10-29 | 1978-01-31 | Merck & Co., Inc. | Antibiotic A21A |
US4218560A (en) * | 1977-10-25 | 1980-08-19 | Hoffmann-La Roche Inc. | Esters of antibiotic X-5108 and of mocimycin |
DE2921213A1 (de) * | 1979-05-25 | 1980-12-11 | Henkel Kgaa | Tierfuttermischung |
-
1981
- 1981-04-20 US US06/255,901 patent/US4336250A/en not_active Expired - Lifetime
-
1982
- 1982-04-14 GR GR67930A patent/GR76132B/el unknown
- 1982-04-19 AT AT82301995T patent/ATE16886T1/de active
- 1982-04-19 DE DE8282301995T patent/DE3267876D1/de not_active Expired
- 1982-04-19 FI FI821347A patent/FI821347L/fi not_active Application Discontinuation
- 1982-04-19 AU AU82817/82A patent/AU548281B2/en not_active Expired
- 1982-04-19 GB GB8211261A patent/GB2098479B/en not_active Expired
- 1982-04-19 ZA ZA822658A patent/ZA822658B/xx unknown
- 1982-04-19 EP EP82301995A patent/EP0063490B1/fr not_active Expired
- 1982-04-19 IE IE911/82A patent/IE53057B1/en not_active IP Right Cessation
- 1982-04-19 DK DK173682A patent/DK173682A/da active IP Right Grant
- 1982-04-19 HU HU821201A patent/HU183897B/hu unknown
- 1982-04-19 NZ NZ200343A patent/NZ200343A/en unknown
- 1982-04-19 PH PH27159A patent/PH16912A/en unknown
- 1982-04-19 IL IL65523A patent/IL65523A/xx unknown
- 1982-04-19 JP JP57066184A patent/JPS57181016A/ja active Pending
- 1982-04-19 NO NO821268A patent/NO821268L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NZ200343A (en) | 1986-01-24 |
GB2098479B (en) | 1984-09-19 |
PH16912A (en) | 1984-04-10 |
AU548281B2 (en) | 1985-12-05 |
DK173682A (da) | 1982-12-06 |
EP0063490B1 (fr) | 1985-12-11 |
IL65523A (en) | 1985-03-31 |
DE3267876D1 (en) | 1986-01-23 |
HU183897B (en) | 1984-06-28 |
ZA822658B (en) | 1983-02-23 |
GB2098479A (en) | 1982-11-24 |
IL65523A0 (en) | 1982-07-30 |
AU8281782A (en) | 1982-10-28 |
ATE16886T1 (de) | 1985-12-15 |
JPS57181016A (en) | 1982-11-08 |
US4336250A (en) | 1982-06-22 |
IE53057B1 (en) | 1988-05-25 |
IE820911L (en) | 1982-10-20 |
GR76132B (fr) | 1984-08-03 |
FI821347L (fi) | 1982-10-21 |
EP0063490A1 (fr) | 1982-10-27 |
FI821347A0 (fi) | 1982-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Palmquist et al. | Effect of dietary fat and calcium source on insoluble soap formation in the rumen | |
Mohammed et al. | A review on effects of yeast (Saccharomyces cerevisiae) as feed additives in ruminants performance | |
Cummins et al. | Effect of isocarbon-4 and isocarbon-5 volatile fatty acids on microbial protein synthesis and dry matter digestibility in vitro | |
KR20100102633A (ko) | 반추위 발효를 개선하기 위한 시트릭 플라보노이드 혼합물 | |
Rusoff et al. | Growth-promoting effect of aureomycin on young calves weaned from milk at an early age | |
NO821268L (no) | Fremgangsmaate for forbedring av melkedannelse hos droevtyggere | |
Hassan et al. | Effect of Saccaromyces cerevisiae supplementation on rumen characteristics in awassi lambs fed diets with different roughage to concentrate ratios. | |
CA2229560C (fr) | Complement alimentaire pour ruminants renfermant un amide aliphatique | |
Drackley et al. | Ration digestibilities and ruminal characteristics in steers fed sunflower seeds with additional calcium | |
US4185091A (en) | Use of avilamycin as a feed additive | |
EP0091649A1 (fr) | Procédé pour augmenter l'efficacité de la fermentation de panse de ruminants | |
US4534969A (en) | Method for improving lactation in ruminant animals | |
CN112544800A (zh) | 一种反刍动物用液体饲料添加剂及其制备方法 | |
JP3116506B2 (ja) | 反芻胃の微生物群を増やす方法及び畜産技術の改良方法 | |
US5081146A (en) | Method and feed supplement for the feeding of ruminants | |
US20030129218A1 (en) | Dietary supplement | |
Abd El Tawab et al. | Improving utilization of olive cake silage by treating with fibrolytic enzymes on digestibility and gas production in the rumen | |
Masuda et al. | Effect of sugar-beet pulp supplementation on fiber degradation of grass hay in the rumen of goats | |
NO138400B (no) | Droevtygger-for. | |
NO156922B (no) | Anvendelse av et glykopeptidantibiotikum i for for melkekuer. | |
US4959223A (en) | Ruminant animal feedstuffs | |
Atia et al. | INFLUENCE OF SUPPLEMENTALSHEEP RATION WITH ZINC SOURCE (INORGANIC VS. ORGANIC) ON THEIR DIGESTIBILITY AND RUMINAL FERMENTATION. | |
US5719121A (en) | Use of balhimycin as production promoter in animals, and production promoter compositions | |
Nolte et al. | The effect of rumen degradable protein level and source on the duodenal essential amino acid profile of sheep | |
El-Bordeny et al. | EFFECT OF USING MYCOTOXINS DEACTIVATOR WITH NATURALLY MYCOTOXINS CONTAMINATED OR NOT CONTAMINATED CORN SILAGE ON LACTATING COWS PERFORMANCE |